A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy Volunteers

NCT04931147 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Fibrosis
Inflammation
Idiopathic Pulmonary Fibrosis
Non-alcoholic Steatohepatitis
Liver Diseases
Kidney Diseases

Interventions

DRUG: RXC007
DRUG: RXC007 Matching Placebo

Sponsor

Redx Pharma Ltd

Collaborators

[object Object]